Allegations that false claims regarding treatment were made to potential patients, as well as one of its proponents having at least one fake degree, are being leveled against a stem cell clinic that was operating in India two years ago.
The clinic was not offering HSCT, but rather a form of combination therapy involving the use of stem cells and “liberation therapy” associated with CCSVI. This is the controversial condition that was unknown until an Italian doctor, Paolo Zamboni, coined the term ‘chronic cerebrospinal venous insufficiency’ when he reported in 2009 that virtually all MS patients have this vein narrowing disorder.
As early as 2013, a study led by the University of British Columbia, in Canada, came to the conclusion that MS patients are no more liable to have CCSVI than anyone else. Zamboni still maintains that MS patients can benefit from having their neck veins dilated through an angioplasty procedure called liberation therapy. This is meant to improve blood flow between the brain and the heart, and clear out iron deposits.
However, even using Dr. Zamboni’s own methods, equipment, and his direct instruction to technologists who went to Italy to learn from him, Canadian researchers were unable to replicate the Italian doctor’s stunning results.
MS not caused by neck veins, study shows
Instead, the researchers found that MS patients and healthy controls shared the same prevalence of vein constriction, suggesting it has nothing to do with MS.
Lead researcher Dr. Anthony Traboulsee (pictured, right) said that the study proves the cause of MS cannot be attributed to the shape of cervical (neck) veins, but added that, in medicine, even wrong theories have led to important discoveries.
So, the question remains as to why a company, incidentally also Canadian, was behind the Indian clinic promoting just such a treatment, allegedly making false claims about it, to people with MS —even as long as a year after Dr. Traboulsee’s peer-reviewed study found that MS patients were unlikely to benefit.
I am aware that an investigation is underway in Canada, and there is no way that this writer is going to prejudice its outcome and so will not include the name of the company or those of its then senior operatives at this time. What I can say is that there is evidence that one or more representatives of this company were selling a questionable stem cell therapy protocol in India to people with MS and ALS all over the world, including in the U.S., Canada, Europe, and Australia. (Details are easily found online, however. Those curious about them, or wanting to confirm statements in this blog, can follow this link to an article in the Winnipeg Free Press and this link to an article by CBC News.)
One MS patient, whose identity I have been asked to withhold, has told me: “I signed up for the stem cell therapy (called Combination Therapy Protocol or CTP) and was treated in India in May 2014. We were told it was a one-time treatment that halted the disease and that all former patients had symptom improvement. It has since been discovered that most patients had short-term improvement, followed by decline, and in some cases are in worse condition now. These patients feel they have been conned.”
We are sorry that this post was not useful for you!
Let us improve this post!
Tell us how we can improve this post?